Features of 20 133 UK patients in hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: prospective observational cohort study

…, L Merson, J Lee, D Plotkin, L Sigfrid, S Halpin… - bmj, 2020 - bmj.com
Objective To characterise the clinical features of patients admitted to hospital with coronavirus
disease 2019 (covid-19) in the United Kingdom during the growth phase of the first wave …

Risk stratification of patients admitted to hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: development and validation of the 4C …

…, CJ Fairfield, C Gamble, CA Green, R Gupta, S Halpin… - bmj, 2020 - bmj.com
Objective To develop and validate a pragmatic risk score to predict mortality in patients admitted
to hospital with coronavirus disease 2019 (covid-19). Design Prospective observational …

Clinical characteristics of children and young people admitted to hospital with covid-19 in United Kingdom: prospective multicentre observational cohort study

…, TM Drake, S Seth, C Egan, HE Hardwick, S Halpin… - bmj, 2020 - bmj.com
Objective To characterise the clinical features of children and young people admitted to
hospital with laboratory confirmed severe acute respiratory syndrome coronavirus 2 (SARS-CoV-…

Features of 16,749 hospitalised UK patients with COVID-19 using the ISARIC WHO Clinical Characterisation Protocol

…, L Merson, J Lee, D Plotkin, L Sigfrid, S Halpin… - MedRxiv, 2020 - medrxiv.org
Structured abstract Objective To characterize the clinical features of patients with severe
COVID-19 in the UK. Design Prospective observational cohort study with rapid data gathering …

[HTML][HTML] Co-infections, secondary infections, and antimicrobial use in patients hospitalised with COVID-19 during the first pandemic wave from the ISARIC WHO CCP …

…, J Harrison, L Marsh, M Connor, S Halpin… - The Lancet …, 2021 - thelancet.com
Background Microbiological characterisation of co-infections and secondary infections in
patients with COVID-19 is lacking, and antimicrobial use is high. We aimed to describe …

[HTML][HTML] Development and validation of the ISARIC 4C Deterioration model for adults hospitalised with COVID-19: a prospective cohort study

…, C Gamble, CA Green, S Halpin… - The Lancet …, 2021 - thelancet.com
Background Prognostic models to predict the risk of clinical deterioration in acute COVID-19
cases are urgently required to inform clinical management decisions. Methods We …

[HTML][HTML] Characterisation of in-hospital complications associated with COVID-19 using the ISARIC WHO Clinical Characterisation Protocol UK: a prospective …

…, S Roberts, J Harrison, L Marsh, M Connor, S Halpin… - The Lancet, 2021 - thelancet.com
Background COVID-19 is a multisystem disease and patients who survive might have in-hospital
complications. These complications are likely to have important short-term and long-…

[HTML][HTML] Risk of adverse outcomes in patients with underlying respiratory conditions admitted to hospital with COVID-19: a national, multicentre prospective cohort …

…, J Harrison, L Marsh, M Connor, S Halpin… - The Lancet …, 2021 - thelancet.com
Background Studies of patients admitted to hospital with COVID-19 have found varying
mortality outcomes associated with underlying respiratory conditions and inhaled corticosteroid …

[HTML][HTML] The clinical and cost-effectiveness of total versus partial knee replacement in patients with medial compartment osteoarthritis (TOPKAT): 5-year outcomes of a …

…, C Boachie, D Collins, J Cruden, S Halpin… - The Lancet, 2019 - thelancet.com
Background Late-stage isolated medial knee osteoarthritis can be treated with total knee
replacement (TKR) or partial knee replacement (PKR). There is high variation in treatment …

[HTML][HTML] SARS-CoV-2-specific nasal IgA wanes 9 months after hospitalisation with COVID-19 and is not induced by subsequent vaccination

…, M Connor, J Dalton, C Gamble, M Girvan, S Halpin… - …, 2023 - thelancet.com
Background Most studies of immunity to SARS-CoV-2 focus on circulating antibody, giving
limited insights into mucosal defences that prevent viral replication and onward transmission. …